Zobrazeno 1 - 10
of 124
pro vyhledávání: '"William J Kostuk"'
Autor:
Lizanne M Bussières, Peter W Pflugfelder, Albert W Taylor, Dildar Ahmad, Corinne Weernink, William J Kostuk
Publikováno v:
Canadian Respiratory Journal, Vol 4, Iss 2, Pp 81-87 (1997)
OBJECTIVE: To evaluate the changes in the cardiopulmonary response to exercise in the first year after cardiac transplantation in patients enrolled in a rehabilitation program in the first three months post-transplantation.
Externí odkaz:
https://doaj.org/article/68fae10e1bd84c7cba3b8ba8961aac53
Autor:
G.B. John Mancini, William E. Boden, Koon K. Teo, John A. Spertus, Pamela M. Hartigan, Daniel S. Berman, David J. Maron, William S. Weintraub, William J. Kostuk
Publikováno v:
Journal of the American College of Cardiology. 73:2049-2058
Background The importance of glycosylated hemoglobin A1c (A1c) control as part of comprehensive risk factor management in patients with stable ischemic heart disease (SIHD) and diabetes mellitus (DM) is controversial. Objectives The purpose of this s
Autor:
David J. Maron, William E. Boden, William J. Kostuk, Pamela M. Hartigan, John A. Spertus, G.B. John Mancini, Koon K. Teo, William S. Weintraub, Steven P. Sedlis, Daniel S. Berman
Publikováno v:
Journal of the American College of Cardiology. 72(19)
Individual risk factor control improves survival in patients with stable ischemic heart disease (SIHD). It is uncertain if multiple risk factor control further extends survival.This study determined whether a greater number of risk factors at goal pr
Autor:
Marcin Dada, Paul Chan, Koon K. Teo, Brahmajee K. Nallamothu, William J. Kostuk, Steven P. Sedlis, Pamela M. Hartigan, G.B. John Mancini, William S. Weintraub, Steven M. Bradley, Daniel S. Berman, David J. Maron, William E. Boden, John A. Spertus
Publikováno v:
The American Journal of Cardiology. 116:167-173
Establishing the validity of appropriate use criteria (AUC) for percutaneous coronary intervention (PCI) in the setting of stable ischemic heart disease can support their adoption for quality improvement. We conducted a post hoc analysis of 2,287 Cli
Autor:
Zugui Zhang, William J. Kostuk, William S. Weintraub, David J. Maron, John A. Spertus, G.B. John Mancini, Steven P. Sedlis, William E. Boden, Koon K. Teo, Philip G. Jones, Pamela M. Hartigan, Daniel S. Berman
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 11(5)
Background: Percutaneous coronary intervention (PCI) is a therapy to reduce angina and improve quality of life in patients with stable ischemic heart disease. However, it is unclear whether the quality of life after PCI is more dependent on the PCI o
Autor:
G.B. John Mancini, Paolo Raggi, Rodney Zimmermann, Beth L. Abramson, William J. Kostuk, Kim A. Connelly, Gilbert Gosselin, Benjamin J.W. Chow, Michael E. Farkouh, James A. Stone, Kenneth J. Yvorchuk, Blair J. O'Neill, Martin Juneau, Koon K. Teo, Raymond Cartier, Victor F. Huckell, Jean-Claude Tardif, Subodh Verma, John Ducas, Milan Gupta
Publikováno v:
Canadian Journal of Cardiology. 30:837-849
This overview provides a guideline for the management of stable ischemic heart disease. It represents the work of a primary and secondary panel of participants from across Canada who achieved consensus on behalf of the Canadian Cardiovascular Society
Autor:
Pamela M. Hartigan, David J. Maron, G.B. John Mancini, Steven P. Sedlis, William J. Kostuk, Leslee J. Shaw, Marcin Dada, William S. Weintraub, Eric R. Bates, Sean W. Hayes, David C. Booth, Daniel S. Berman, John A. Spertus, Bernard R. Chaitman, William E. Boden, Koon K. Teo
Publikováno v:
JACC: Cardiovascular Interventions. 7(2):195-201
Objectives The aim of this study was to determine the relative utility of anatomic and ischemic burden of coronary artery disease for predicting outcomes. Background Both anatomic burden and ischemic burden of coronary artery disease determine patien
Autor:
Pamela M. Hartigan, William S. Weintraub, G.B. John Mancini, Subroto Acharjee, Steven P. Sedlis, William E. Boden, John A. Spertus, David J. Maron, Koon K. Teo, Bernard R. Chaitman, William J. Kostuk, Marcin Dada
Publikováno v:
Journal of the American College of Cardiology. 62:1826-1833
Objectives This study sought to assess the independent effect of high-density lipoprotein-cholesterol (HDL-C) level on cardiovascular risk in patients with stable ischemic heart disease (SIHD) who were receiving optimal medical therapy (OMT). Backgro
Autor:
William J. Kostuk, Cathy A. Sila, Salvador Cruz-Flores, Robert J. Padley, Koon K. Teo, David C. Anderson, Shannon Grant, Larry B. Goldstein, Bernard R. Chaitman, William E. Boden, William S. Weintraub
Publikováno v:
Stroke. 44:2688-2693
Background and Purpose— In Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcomes (AIM-HIGH) trial, addition of extended-release niacin (ERN) to simvastatin in participants with establi
Autor:
Bernard R. Chaitman, William E. Boden, Pamela M. Hartigan, William J. Kostuk, Marcin Dada, Koon K. Teo, G.B. John Mancini, Daniel S. Berman, David J. Maron, Steven P. Sedlis, Merril L. Knudtson, John A. Spertus, David C. Booth, William S. Weintraub, Eric R. Bates
Publikováno v:
American Heart Journal. 166:481-487
It is unknown if baseline angiographic findings can be used to estimate residual risk of patients with chronic stable angina treated with both optimal medical therapy (OMT) and protocol-assigned or symptom-driven percutaneous coronary intervention (P